Home >> Tag Archives: SpeeDx—

Tag Archives: SpeeDx—

CE-IVD mark for PlexPCR VHS test, 2/18

February 2018—SpeeDx announced it has received CE-IVD marking for its PlexPCR VHS multiplex qPCR test. The test offers a single-well solution to cover the detection and differentiation of the main causes of genital and oral lesions—herpes simplex virus types 1 and 2, Treponema pallidum (syphilis), and varicella zoster virus.

Read More »

Distribution partnership for SpeeDx, Cepheid, 7/17

July 2017—SpeeDx announced an agreement with Cepheid for distribution of its PlexPCR and ResistancePlus molecular diagnostic products in key markets throughout Europe. The agreement, covering Germany, France, Italy, and the U.K., will increase coverage for the ResistancePlus MG test, a CE-IVD test for the sexually transmitted infection Mycoplasma genitalium that combines detection with testing for azithromycin resistance.

Read More »

CE mark for herpes virus test, 9/16

September 2016—SpeeDx received CE-IVD marking for its PlexPCR HSV-1&2, VZV multiplex qPCR kit. The multiplex molecular diagnostic test offers a single-well solution to cover the detection and differentiation of three herpes viruses (HSV-1, HSV-2, VZV) in addition to an internal control.

Read More »

SpeeDx lands CE mark for multiplex herpes test

Sept. 6, 2016—SpeeDx has received CE-IVD marking for its PlexPCR HSV 1 and 2, VZV multiplex qPCR kit. The multiplex molecular diagnostic test offers a single-well solution to cover the detection and differentiation of three herpes viruses (HSV 1, HSV 2, and varicella zoster virus) in addition to an internal control. Validated for use on multiple lesion specimen types, the ...

Read More »
X